Literature DB >> 14455345

A clinical trial of prenylamine lactate--a long-lasting coronary dilator drug.

D F KERRIDGE, S J MAZURKIE, D VEREL.   

Abstract

Entities:  

Keywords:  ANGINA PECTORIS/therapy; VASODILATOR AGENTS/therapy

Mesh：

Substances：

Year:  1961        PMID： 14455345      PMCID： PMC1848641     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  [A new coronary vasodilator. Experimental and clinical studies].

Authors:  C BOEHM; M SCHLEPPER; E WITZLEB
Journal:  Dtsch Med Wochenschr       Date:  1960-08-05       Impact factor: 0.628

2.  Clinical evaluation of a new coronary vasodilator, 3-dimethylamino-1,1 2-tris (4-methoxyphenyl)-1-propene hydrochloride (WIN 5494).

Authors:  G SANDLER
Journal:  Am Heart J       Date:  1960-05       Impact factor: 4.749
  2 in total
  3 in total

1.  To-day's Drugs.

Authors: 
Journal:  Br Med J       Date:  1963-07-13

2.  Lidoflazine: double-blind trial of a new coronary vasodilator in angina pectoris.

Authors:  B Brantmark; N Egelius; E Fabricius; M Jemt; G Palmborg; J Philipson; N Rönnegård
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

Review 3.  Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Authors:  Rashmi R Shah; Peter D Stonier
Journal:  Ther Adv Drug Saf       Date:  2018-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.